Humana Inc. (HUM)
$
264.6
+0.02 (0.01%)
Key metrics
Financial statements
Free cash flow per share
19.8580
Market cap
32.1 Billion
Price to sales ratio
0.2728
Debt to equity
0.7158
Current ratio
1.4217
Income quality
2.4371
Average inventory
0
ROE
0.0723
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Humana Inc., along with its subsidiaries, is a prominent health and well-being company operating in the United States through three distinct segments: Retail, Group and Specialty, and Healthcare Services. The company reported depreciation and amortization expenses of $968,000,000.00 reflecting the wear and tear of its assets. Additionally, the net total of other income and expenses is -$935,000,000.00 highlighting its engagement in non-core financial activities. The company reported an income before tax of $1,627,000,000.00 showcasing its pre-tax profitability, while incurring an interest expense of $660,000,000.00 reflecting its debt servicing obligations. The cost of revenue for the company is $0.00 illustrating its production and operational expenses. Humana offers a range of medical and supplemental benefit plans tailored for individuals and maintains contracts with the Centers for Medicare and Medicaid Services to manage the Limited Income Newly Eligible Transition prescription drug plan program. Furthermore, it collaborates with various states to deliver Medicaid, dual eligible, and long-term support services benefits, as well as providing commercial fully insured medical and specialty health insurance benefits that include dental, vision, and other supplemental options. The company also administers services solely for its employer groups and individual clients, alongside military services like the TRICARE T2017 East Region contract. With a substantial membership base, as of December 31, 2021, the company had around 17 million members in medical benefit plans and approximately 5 million in specialty products. In terms of market performance, the stock is priced at $263.27 positioning it in the higher-end market. It shows a high average trading volume of 1,583,123.00 indicating strong liquidity, while maintaining a mid-range market capitalization of $31,935,367,800.00 categorizing the company as a steady performer. As a key player in the Medical - Healthcare Plans industry, Humana contributes significantly to the overall market landscape and belongs to the Healthcare sector, driving innovation and growth. Through its expansive offerings and substantial member base, Humana Inc. continues to impact the health and well-being of millions while leveraging its financial performance and market position to sustain its growth objectives.
What is Humana Inc. (HUM)'s stock forecast?
Analysts predict Humana Inc. stock to fluctuate between $213.31 (low) and $406.46 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Humana Inc.'s market capitalization?
As of 2025-04-01, Humana Inc.'s market cap is $31,935,367,800, based on 120,693,000 outstanding shares.
How does Humana Inc. compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., Humana Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Humana Inc. (HUM) stock?
To buy Humana Inc. (HUM) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for HUM. Place an order (Market, Limit, etc.).
What is the best time to invest in Humana Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
How did Humana Inc. perform in the last earnings report?
Revenue: $117,761,000,000 | EPS: $10.01 | Growth: -50.17%.
Where can I find Humana Inc.'s investor relations reports?
Visit https://www.humana.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Humana Inc.?
You can explore historical data from here
What is the all-time high and low for Humana Inc. stock?
All-time high: $571.30 (2022-11-03) | All-time low: $213.31 (2024-10-02).
What are the key trends affecting Humana Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
globenewswire.com
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Humana Inc. (NYSE: HUM) on behalf of long-term stockholders following a class action complaint that was filed against Humana on June 3, 2024 with a Class Period from July 27, 2022, to January 24, 2024.
zacks.com
HUM's CenterWell and Conviva partner with Icon Health, improving musculoskeletal care access for seniors.
businesswire.com
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a public offering of $1.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $750 million of the company's 5.550 percent senior notes, due 2035, at 99.885 percent of the principal amount and $500 million of the company's 6.000 percent senior notes, due 2055, at 98.951 percent of the principal amount (collectively, the “Senior Notes Offerings”). Th.
businesswire.com
LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM), is donating $250,000 in support of relief and recovery efforts for Kentuckians impacted by destructive flooding in Eastern Kentucky. Following the flooding, some areas were also hit by winter snowstorm activity. Over the past week, torrential rains fell across Kentucky causing flooding in some areas while overflowing rivers onto neighborhoods and communities. At least 14 people died due to.
marketbeat.com
The medical sector giant was one of the first carriers to sound the alarm of rising inpatient utilization costs, notably with its Medicare Advantage (MA) plan members in Q4 2023.
businesswire.com
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on April 25, 2025 to stockholders of record as of the close of business on March 28, 2025. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of.
benzinga.com
Health insurance company Humana HUM is set to release its fourth-quarter 2024 earnings report on Feb. 11, before market hours. The stock has dropped 2.37% from the previous close, as of writing, on Feb.10, according to Benzinga Pro.
zacks.com
HUM's Q4 results are likely to suffer a blow due to escalating operating costs, partly offset by membership growth in the Individual and Group Medicare Advantage business lines.
zacks.com
Besides Wall Street's top -and-bottom-line estimates for Humana (HUM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.
globenewswire.com
With its groundbreaking AI Care platform fueling rapid growth, Sword is transforming healthcare through AI. The addition of Bruce Broussard as Board Advisor will be instrumental in enhancing industry expertise and shaping the company's future. With its groundbreaking AI Care platform fueling rapid growth, Sword is transforming healthcare through AI. The addition of Bruce Broussard as Board Advisor will be instrumental in enhancing industry expertise and shaping the company's future.
See all news
